awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34086952-109EB5D9-801C-4992-95F3-4E5FD5A207FE
Q34086952-109EB5D9-801C-4992-95F3-4E5FD5A207FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086952-109EB5D9-801C-4992-95F3-4E5FD5A207FE
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
P2860
Q34086952-109EB5D9-801C-4992-95F3-4E5FD5A207FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086952-109EB5D9-801C-4992-95F3-4E5FD5A207FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c087fc29f5bb77a85fca547ca0564a8eccdd28c9
P2860
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.